Download the
Clinical Development Success Rates Study

BioMedTracker, Amplion, and BIO have released the largest study ever on clinical development success rates. This report examines success rates across ~10,000 clinical program transitions by therapeutic area as well as three unique categories: rare diseases, chronic high prevalence diseases, and programs utilizing selection biomarkers. The results show dramatic differences between disease groups and modalities.